Breaking News Instant updates and real-time market news.

2020-04-22 07:55:05 NFLX Netflix $434.01 / -3.65 (-0.83%) 07:55 04/22/20 04/22 07:55 04/22/20 07:55	Netflix price target raised to $500 from $400 at Deutsche Bank Deutsche Bank analyst Bryan Kraft raised the firm's price target on Netflix to $500 from $400 and keeps a Buy rating on the shares following last night's Q1 results. While the stock has outperformed throughout the COVID-19 crisis, the outperformance is justified given Netflix's unique position of being exposed to secular growth that is accelerating as a result of worldwide stay-at-home orders, Kraft tells investors in a research note. The analyst does not believe these benefits are transitory, thinking they represent an acceleration in the pace of secular adoption of streaming video and of Netflix in particular.
NFLX Netflix $434.01 / -3.65 (-0.83%) 04/22/20 Oppenheimer Netflix price target raised to $480 from $400 at Oppenheimer 04/22/20 Rosenblatt Netflix pull forward comments should pause momentum in shares, says Rosenblatt 04/22/20 Canaccord Netflix price target raised to $500 from $450 at Canaccord 04/22/20 Credit Suisse Netflix price target raised to $465 from $440 at Credit Suisse

2020-04-22 07:55:05

NFLX

Netflix

$434.01 / -3.65 (-0.83%)

07:55

04/22/20

04/22

07:55

04/22/20

07:55

Netflix price target raised to $500 from $400 at Deutsche Bank

Deutsche Bank analyst Bryan Kraft raised the firm's price target on Netflix to $500 from $400 and keeps a Buy rating on the shares following last night's Q1 results. While the stock has outperformed throughout the COVID-19 crisis, the outperformance is justified given Netflix's unique position of being exposed to secular growth that is accelerating as a result of worldwide stay-at-home orders, Kraft tells investors in a research note. The analyst does not believe these benefits are transitory, thinking they represent an acceleration in the pace of secular adoption of streaming video and of Netflix in particular.

NFLX Netflix

$434.01 / -3.65 (-0.83%)

04/22/20 Oppenheimer: Netflix price target raised to $480 from $400 at Oppenheimer

04/22/20 Rosenblatt: Netflix pull forward comments should pause momentum in shares, says Rosenblatt

04/22/20 Canaccord: Netflix price target raised to $500 from $450 at Canaccord

04/22/20 Credit Suisse: Netflix price target raised to $465 from $440 at Credit Suisse

TODAY'S FREE FLY STORIES

General news	8-Week Bill Announcement Offering Amount data reported » 11:06 03/02/21 03/02 11:06 03/02/21 11:06 8-Week Bill Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	4-Week Bill Announcement Offering Amount data reported » 11:06 03/02/21 03/02 11:06 03/02/21 11:06 4-Week Bill Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Periodicals	PayPal in the process of buying Curv for up to $500M, CoinDesk reports » 11:06 03/02/21 03/02 11:06 03/02/21 11:06 PYPL PayPal $270.15 / -3.39 (-1.24%) PayPal is in the process… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PYPL PayPal $270.15 / -3.39 (-1.24%) 02/17/21 PayPal CEO sells 10K shares of common stock 02/17/21 PayPal's Sarnoff sells 5,290 common shares 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/08/21 PayPal CEO sells 10K shares of common stock PYPL PayPal $270.15 / -3.39 (-1.24%) 02/16/21 BTIG PayPal price target raised to $345 from $300 at BTIG 02/12/21 Keefe Bruyette PayPal price target raised to $340 from $290 at Keefe Bruyette 02/12/21 Loop Capital PayPal price target raised to $321 from $291 at Loop Capital 02/12/21 Raymond James PayPal price target raised to $333 from $296 at Raymond James PYPL PayPal $270.15 / -3.39 (-1.24%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/03/21 PayPal sees Q1 adjusted EPS growth of about 50%, consensus 99c 02/03/21 PayPal sees FY21 adjusted EPS up about 17%, consensus $4.54 02/03/21 PayPal reports Q4 adjusted EPS $1.08, consensus $1.00 PYPL PayPal $270.15 / -3.39 (-1.24%) 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 02/12/21 PayPal not likely to invest cash in cryptocurrencies, CFO tells CNBC 02/11/21 PayPal sees EPS growing at 22% CAGR over five years, Bloomberg says 12/29/20 Beijing seeking larger stake in Jack Ma's businesses, WSJ reports PYPL PayPal $270.15 / -3.39 (-1.24%) 02/23/21 Fly Intel: What to watch in Square earnings report 02/12/21 The Intersection: Crypto and Wall Street This Week 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Technology, Media & Telecom Virtual Conference PYPL PayPal $270.15 / -3.39 (-1.24%) 02/12/21 Unusually active option classes on open February 12th 02/04/21 Early notable gainers among liquid option names on February 4th 02/04/21 Notable open interest changes for February 4th 02/03/21 PayPal options imply 10.1% move in share price post-earnings
Hot Stocks	Bit Digital announces bitcoin mining production of 424.7 bitcoin for January » 11:06 03/02/21 03/02 11:06 03/02/21 11:06 BTBT Bit Digital $15.90 / -0.7 (-4.22%) Bit Digital announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options BTBT Bit Digital $15.90 / -0.7 (-4.22%) 02/03/21 Bit Digital removes Min Hu as CEO, appoints Erke Huang as interim CEO 01/19/21 Bit Digital responds to accusations and publishes report in SEC's website 12/28/20 Cryptocurrency mining related names rise after Bitcoin spike this weekend 12/04/20 Bit Digital completes acquisition of $13,902,742 worth of bitcoin miners BTBT Bit Digital $15.90 / -0.7 (-4.22%) 01/11/21 J Capital announces short position in Bit Digital, sees 'death spiral' 01/11/21 Bit Digital discussed as potential short on Wolfpack podcast BTBT Bit Digital $15.90 / -0.7 (-4.22%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 12/28/20 Fly Intel: Pre-market Movers BTBT Bit Digital $15.90 / -0.7 (-4.22%) 02/16/21 Bit Digital call volume above normal and directionally bullish 02/09/21 Bit Digital call buyer realizes 154% same-day gains 02/09/21 Unusual call flow in option market yesterday 02/08/21 Call buyers mining for crypto upside in Bit Digital
Options	Square call volume above normal and directionally bullish » 11:05 03/02/21 03/02 11:05 03/02/21 11:05 SQ Square $253.89 / +12.91 (+5.36%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SQ Square $253.89 / +12.91 (+5.36%) 03/01/21 Square says Square Financial Services has begun operations 02/23/21 Square slips over 4% to about $245 after Q4 results 02/23/21 Square sees Q1 non-GAAP product development expenses up approx. $110M 02/23/21 Square: CashApp delivered 164% y/y gross profit growth in January SQ Square $253.89 / +12.91 (+5.36%) 02/25/21 Fly Intel: Top five analyst upgrades 02/25/21 BMO Capital Square price target raised to $237 from $229 at BMO Capital 02/25/21 Guggenheim Square upgraded to Buy from Neutral at Guggenheim 02/25/21 Guggenheim Square upgraded to Buy from Neutral at Guggenheim SQ Square $253.89 / +12.91 (+5.36%) 02/23/21 Square reports Q4 adjusted EPS 32c, consensus 24c 02/23/21 Notable companies reporting after market close 11/05/20 Square reports Q3 adjusted EPS 34c, consensus 16c 11/05/20 Square reports Q3 revenue $3.03B, consensus $2.07B SQ Square $253.89 / +12.91 (+5.36%) 02/24/21 Square CFO says Cash App saw surge in new bitcoin buyers in January, CNBC says 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/24/20 Square held talks to acquire music service Tidal, Bloomberg reports 11/25/20 DOJ wants Intuit to sell Credit Karma tax unit to approve deal, CNBC says SQ Square $253.89 / +12.91 (+5.36%) 02/26/21 The Intersection: Crypto and Wall Street This Week 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday SQ Square $253.89 / +12.91 (+5.36%) 02/23/21 Square options imply 13.4% move in share price post-earnings 12/22/20 Unusual call flow in option market yesterday 12/21/20 Upside call seller takes advantage of all-time high in Square 11/09/20 Square call volume above normal and directionally bullish

Recommendations	Clearside enrollment speed 'encouraging,' says Roth Capital » 11:04 03/02/21 03/02 11:04 03/02/21 11:04 CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) 07:54 Today Clearside completes dosing in first cohort of Phase 1/2a trial of CLS-AX 02/16/21 Clearside Biomedical announces presentation on CLS-AX 02/08/21 Clearside featured in multiple data presentations at Macula Society meeting 01/12/21 Clearside Biomedical enrolls first patients in Phase 1/2a trial of CLS-AX CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) 12/03/20 Roth Capital Clearside platform validated by Janssen deal, says Roth Capital 08/06/20 Roth Capital Investors should buy 'highly undervalued' Clearside, says Roth Capital 06/19/20 Roth Capital Clearside Biomedical abstracts highlight strength, says Roth Capital 05/13/20 Fly Intel: Top five analyst initiations CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) 11/10/20 Clearside Biomedical reports Q EPS , consensus 03/15/21 33rd Annual Roth Virtual Conference 03/10/21 Clearside Biomedical - CLSD
Upgrade	Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback » 11:04 03/02/21 03/02 11:04 03/02/21 11:04 ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) , BAYRY Bayer $0.00 / + (+0.00%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 02/08/21 Atara Biotherapeutics to present tabelecleucel data at ASTCT meeting 01/04/21 Atara Biotherapeutics provides update on BLA submission for tab-cel 12/07/20 Atara presents evaluation of CAR T Cell Therapy ATA3219 at ASH 12/07/20 Bayer, Atara Biotherapeutics enter collaboration on CAR T-cell therapies BAYRY Bayer $0.00 / + (+0.00%) 02/24/21 Bayer to divest Environmental Science Professional business 02/17/21 Selecta, AskBio initiate first-in-human dose escalation study of ImmTOR 02/05/21 CureVac enters pact with UK Government to develop SARS-CoV-2 variant vaccine 02/03/21 Bayer announes $2B agreement to resolve future Roundup cases ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 11:00 Today Citi Atara Biotherapeutics upgraded to Buy from Neutral at Citi 01/04/21 Roth Capital Roth keeps Buy rating on Atara Biotherapeutics after filing delay 01/04/21 Roth Capital Roth keeps Buy rating on Atara as initiation of BLA gets 'slightly' delayed 12/09/20 Citi Atara Biotherapeutics downgraded to Neutral from Buy at Citi BAYRY Bayer $0.00 / + (+0.00%) 03/01/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 68 at Morgan Stanley 02/26/21 Credit Suisse Bayer price target raised to EUR 56 from EUR 55 at Credit Suisse 02/10/21 Barclays Bayer price target raised to EUR 55 from EUR 50 at Barclays 02/04/21 Citi opens positive 'Catalyst Watch' on Bayer ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 03/01/21 Atara Biotherapeutics reports Q4 EPS (95c), consensus (74c) 11/12/20 Atara Biotherapeutics to present preclinical data on ATA3271 at SITC 2020 11/09/20 Atara Biotherapeutics reports Q3 EPS (92c), consensus ($1.09) BAYRY Bayer $0.00 / + (+0.00%) 02/25/21 Bayer sees 2021 core EPS approx. EUR5.60-EUR5.80 02/25/21 Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 09 Dec 27 May BAYRY BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 12/07/20 Fly Intel: Pre-market Movers BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/29/20 Fly Intel: Wall Street's top stories for Tuesday
Hot Stocks	Capri Holdings appoints Alejandro Martinez-Galindo as CIO » 11:04 03/02/21 03/02 11:04 03/02/21 11:04 CPRI Capri Holdings $47.97 / -0.26 (-0.54%) , WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) Capri Holdings (CPRI)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/03/21 Capri Holdings sees lower Q4 revenue than previously expected 01/07/21 Capri Holdings to replace Enphase Energy in the S&P 400 at open on January 7 01/06/21 Celsius Holdings confirms addition to S&P SmallCap 600 Index, effective Jan. 7 12/30/20 Capri Holdings to replace Enphase Energy in the S&P 400 at open on January 7 WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 02/24/21 Walgreens says Pixel by Labcorp COVID-19 PCR test to be available OTC nationwide 02/24/21 CRL makes first at-home COVID-19 saliva test available through Walgreens 02/23/21 Walgreens launches rollout of same-day delivery with Instacart 02/19/21 Walgreens provides over 3M COVID-19 vaccinations CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/04/21 Capri Holdings price target raised to $52 from $50 at Barclays 01/29/21 Baird Capri upgraded to Outperform on multi-year recovery at Baird 01/29/21 Baird Capri Holdings upgraded to Outperform from Neutral at Baird 01/27/21 Citi Capri Holdings price target raised to $53 from $32 at Citi WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 01/27/21 Deutsche Bank Walgreens Boots Alliance price target raised to $49 from $44 at Deutsche Bank 01/15/21 Baird Walgreens Boots Alliance price target raised to $64 from $55 at Baird 01/11/21 Fly Intel: Top five analyst upgrades 01/11/21 Baird Baird upgrades Walgreens Boots Alliance following Q1 results CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/03/21 Capri Holdings reports Q3 adjusted EPS $1.65, consensus $1.01 11/05/20 Capri Holdings sees Q3 sales down double digits, consensus $1.27B 11/05/20 Capri Holdings sees FY sales down approximately 30%, consensus $3.79B 11/05/20 Capri Holdings not providing earnings guidance for FY21 WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 01/07/21 Walgreens Boots Alliance backs FY21 adjusted EPS view up low single digits 01/07/21 Walgreens Boots Alliance reports Q1 adjusted EPS $1.22, consensus $1.03 01/06/21 Notable companies reporting before tomorrow's open 01/06/21 Notable companies reporting before tomorrow's open CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 10/26/20 Hedgeye adds Capri Holdings to best ideas list, Bloomberg says WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says 01/26/21 Walgreens to name Starbucks executive Roz Brewer as CEO, WSJ says 12/20/20 CDC panel says frontline workers, people over 74 should be next, NYTimes reports CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 12/31/20 Fly Intel: Pre-market Movers 12/30/20 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 01/27/21 Fly Intel: Wall Street's top stories for Wednesday 01/27/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 03/31/21 Walgreens Boots Alliance - WBA CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/10/21 Capri Holdings put volume heavy and directionally bearish 02/08/21 Capri Holdings put volume heavy and directionally bearish 01/29/21 Capri Holdings put volume heavy and directionally bearish 01/27/21 Capri Holdings put volume heavy and directionally bearish WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 02/09/21 Walgreen Boots call volume above normal and directionally bullish 01/29/21 Walgreen Boots call volume above normal and directionally bullish 01/11/21 Early notable gainers among liquid option names on January 11th 12/31/20 Walgreen Boots call volume above normal and directionally bullish
Hot Stocks	Activision Blizzard appoints Frances Townsend as EVP, corporate affairs » 11:02 03/02/21 03/02 11:02 03/02/21 11:02 ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) Activision Blizzard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/23/21 Activision says 'Tony Hawk' remake coming to PS5, Xbox Series, Switch 02/19/21 Blizzard unveils 'Diablo II: Resurrected' for PC, consoles 02/19/21 Activision Blizzard says 'Burning Crusade' expansion coming to 'WoW Classic' 02/19/21 Blizzard unveils 'Blizzard Arcade Collection' for PC, consoles ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/23/21 Benchmark Activision Blizzard price target raised to $118 from $109 at Benchmark 02/19/21 Citi Activision Blizzard price target raised to $110 from $83 at Citi 02/18/21 Argus Activision Blizzard price target raised to $122 from $102 at Argus 02/18/21 Deutsche Bank Activision Blizzard price target raised to $115 from $100 at Deutsche Bank ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/04/21 Activision Blizzard sees FY21 EPS $3.34, consensus $3.51 02/04/21 Activision Blizzard sees Q1 EPS 84c, consensus 65c 02/04/21 Activision Blizzard reports Q4 EPS 76c, consensus $1.18 02/04/21 Notable companies reporting after market close ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/18/21 Saudi Arabia's PIF buys $3.3B worth of Activision, EA, Take-Two, Bloomberg says 02/08/21 ESA proceeds with plans for digital E3 this summer, VGC reports 01/27/21 Activision Blizzard rejects AFL-CIO proposals to diversify hiring, Vice reports 01/22/21 Activision shifts Vicarious Visions studio into Blizzard, Gamesindustry.biz says ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/23/21 Game On: An exclusive talk with Skeleton Crew's Olsson and Murakami 02/16/21 Game On: NPD reports 42% growth in U.S. game spending in January 02/09/21 Game On: Big three publishers report earnings as EA to acquire Glu 02/05/21 Peloton downgrade among today's top calls on Wall Street 03/10/21 2021 Technology, Internet & Services Virtual Conference ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/05/21 Early notable gainers among liquid option names on February 5th 01/19/21 Activision Blizzard call volume above normal and directionally bullish 11/30/20 Activision Blizzard call volume above normal and directionally bullish 11/12/20 Early notable gainers among liquid option names on November 12th
Syndicate	Orion Acquisition opens for trade at $10.05, IPO priced at $10 » 11:00 03/02/21 03/02 11:00 03/02/21 11:00 OPHA Orion Acquisition $0.00 / + (+0.00%) Orion Acquisition, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Upgrade	Atara Biotherapeutics upgraded to Buy from Neutral at Citi » 11:00 03/02/21 03/02 11:00 03/02/21 11:00 ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) Citi analyst Yigal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 02/08/21 Atara Biotherapeutics to present tabelecleucel data at ASTCT meeting 01/04/21 Atara Biotherapeutics provides update on BLA submission for tab-cel 12/07/20 Atara presents evaluation of CAR T Cell Therapy ATA3219 at ASH 12/07/20 Bayer, Atara Biotherapeutics enter collaboration on CAR T-cell therapies ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 01/04/21 Roth Capital Roth keeps Buy rating on Atara Biotherapeutics after filing delay 01/04/21 Roth Capital Roth keeps Buy rating on Atara as initiation of BLA gets 'slightly' delayed 12/09/20 Citi Atara Biotherapeutics downgraded to Neutral from Buy at Citi 12/08/20 H.C. Wainwright Atara Biotherapeutics price target raised to $31 from $28 at H.C. Wainwright ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 03/01/21 Atara Biotherapeutics reports Q4 EPS (95c), consensus (74c) 11/12/20 Atara Biotherapeutics to present preclinical data on ATA3271 at SITC 2020 11/09/20 Atara Biotherapeutics reports Q3 EPS (92c), consensus ($1.09) 09 Dec 27 May ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 12/07/20 Fly Intel: Pre-market Movers
Recommendations	CAE price target raised to C$40 from C$34 at TD Securities » 10:59 03/02/21 03/02 10:59 03/02/21 10:59 CAE CAE $29.48 / -0.47 (-1.57%) TD Securities analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CAE CAE $29.48 / -0.47 (-1.57%) 03/01/21 CAE to acquire L3Harris Technologies military training business for $1.05B 03/01/21 L3Harris Technologies to sell Military Training, Combat Propulsion for $1.45B 02/12/21 CAE sees 2021 CapEx $100M 02/02/21 CAE signs contract with Pyure to assemble anti-COVID-19 air sanitizers CAE CAE $29.48 / -0.47 (-1.57%) 02/16/21 TD Securities CAE price target raised to C$34 from C$33 at TD Securities 02/16/21 Scotiabank CAE price target raised to C$39 from C$38 at Scotiabank 02/16/21 Canaccord CAE price target raised to C$34 from C$32 at Canaccord 01/04/21 CIBC CAE price target raised to C$36 from C$33 at CIBC CAE CAE $29.48 / -0.47 (-1.57%) 02/12/21 CAE reports Q3 EPS ex-items C$0.22 vs. C$0.37 a year ago 11/10/20 CAE reports Q2 EPS C$0.13 vs. C$0.28 a year ago CAE CAE $29.48 / -0.47 (-1.57%) 02/28/21 CAE near deal to acquire L3Harris military-training unit, WSJ reports CAE CAE $29.48 / -0.47 (-1.57%) 11/16/20 Fly Intel: After-Hours Movers 05/19/21 CAE - CAE
Syndicate	NightDragon Acquisition opens at $10.25, IPO priced at $10 per unit » 10:56 03/02/21 03/02 10:56 03/02/21 10:56 NDAC NightDragon Acquisition $0.00 / + (+0.00%) NightDragon Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	Target 'off to a strong start' in February, with comps up 20% » 10:55 03/02/21 03/02 10:55 03/02/21 10:55 TGT Target $175.50 / -10.62 (-5.71%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGT Target $175.50 / -10.62 (-5.71%) 09:57 Today Target says testing new sortation center to expedite online orders 09:16 Today Target says 'our business model is working as intended' 08:52 Today Target not providing FY21 guidance 'in the face of continued uncertainty' 06:38 Today Target reports Q4 digital comparable sales grew 118% TGT Target $175.50 / -10.62 (-5.71%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Stifel Target upgraded to Buy from Hold at Stifel 01/14/21 DA Davidson Target price target raised to $229 from $208 at DA Davidson TGT Target $175.50 / -10.62 (-5.71%) 06:34 Today Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B TGT Target $175.50 / -10.62 (-5.71%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says TGT Target $175.50 / -10.62 (-5.71%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 09:00 Today Target - TGT 09:00 Today Target Corporation TGT Target $175.50 / -10.62 (-5.71%) 09:55 Today Early notable gainers among liquid option names on March 2nd 09:40 Today Unusually active option classes on open March 2nd 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th
Options	Two Harbors put volume heavy and directionally bearish » 10:55 03/02/21 03/02 10:55 03/02/21 10:55 TWO Two Harbors $7.16 / -0.03 (-0.42%) Bearish flow noted in Two… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events TWO Two Harbors $7.16 / -0.03 (-0.42%) 12/18/20 Keefe Bruyette Two Harbors downgraded to Market Perform from Outperform at Keefe Bruyette 12/14/20 Jefferies Two Harbors initiated with a Hold at Jefferies 12/10/20 Barclays Two Harbors downgraded to Equal Weight from Overweight at Barclays 11/24/20 Raymond James Two Harbors downgraded to Market Perform from Outperform at Raymond James TWO Two Harbors $7.16 / -0.03 (-0.42%) 02/09/21 Two Harbors reports Q4 core EPS 30c, consensus 23c 11/04/20 Two Harbors reports Q3 EPS 28c, consensus 24c 05/19/21 Two Harbors Investment Corp

Conference/Events	Seelos Therapeutics participates in a conference call with Benchmark » 10:55 03/02/21 03/02 10:55 03/02/21 10:55 SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) Healthcare Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 02/18/21 Seelos Therapeutics amends agreement to repurchase royalties for SLS-002 01/29/21 Seelos Therapeutics receives patent covering SLS-005 in Australia 01/22/21 Seelos Therapeutics receives Notice of Allowance in Japan for SLS-005 01/15/21 Seelos Therapeutics says first patients dosed in study of SLS-002 SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 09/09/20 Roth Capital Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital 06/23/20 Roth Capital Seelos Therapeutics price target raised to $12 from $8 Roth Capital 26 Jan 12 Mar SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 01/25/21 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 03/10/21 Seelos Therapeutics - SEEL SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 02/23/21 One new option listing and one option delisting on February 23rd
Syndicate	Anzu Special Acquisition Corp I opens at $10, IPO priced at $10 per unit » 10:51 03/02/21 03/02 10:51 03/02/21 10:51 ANZU Anzu Special Acquisition Corp I $0.00 / + (+0.00%) Anzu Special Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Syndicate	Northern Star Investment Corp. IV opens at $10.15, IPO priced at $10 » 10:49 03/02/21 03/02 10:49 03/02/21 10:49 NSTD Northern Star Investment Corp. IV $0.00 / + (+0.00%) Northern Star Investment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Syndicate	Northern Star Investment Corp. III opens a $10.15, IPO priced at $10 » 10:47 03/02/21 03/02 10:47 03/02/21 10:47 NSTC Northern Star Investment Corp. III $0.00 / + (+0.00%) Northern Star Investment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Syndicate	Live Oak Mobility Acquisition opens at $10.29, IPO priced at $10 » 10:45 03/02/21 03/02 10:45 03/02/21 10:45 LOKM Live Oak Mobility Acquisition $0.00 / + (+0.00%) Live Oak Mobility… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Options	Aurora Cannabis call volume above normal and directionally bullish » 10:45 03/02/21 03/02 10:45 03/02/21 10:45 ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/22/21 NJ Governor signs bill to legalize adult-use cannabis 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/16/21 CIBC Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC 02/16/21 GLJ Research Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research 02/12/21 Canaccord Aurora Cannabis price target raised to C$14 from C$11 at Canaccord 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
General news	4-Week Bill Announcement to be released at 11:00 10:45 03/02/21 03/02 10:45 03/02/21 10:45
General news	8-Week Bill Announcement to be released at 11:00 10:45 03/02/21 03/02 10:45 03/02/21 10:45
Conference/Events	Ideaya Biosciences management to meet virtually with Wedbush » 10:44 03/02/21 03/02 10:44 03/02/21 10:44 IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) 02/08/21 Ideaya Biosciences' IND for IDE397 in cancer cleared by FDA 01/19/21 Ideaya Biosciences, Spelman College partner in female African American education 01/11/21 Ideaya Biosciences submits IND application to FDA for intiaition of IDE397 trial 01/05/21 Ideaya Biosciences announces first patient dosed in study of IDE196, crizotinib IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) 01/29/21 Baird Ideaya Biosciences assumed at Outperform at Baird 01/06/21 Northland Ideaya Biosciences named a top pick in small cap biotech at Northland 01/05/21 Roth Capital Ideaya combo trial opens up large opportunity, says Roth Capital 10/06/20 Wedbush Wedbush starts Ideaya Biosciences at Outperform with $21 price target IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) 11/12/20 Ideaya Biosciences reports Q3 EPS (17c) vs. (54c) last year 18 Jun 03/16/21 31st Annual Healthcare Virtual Conference 03/08/21 Ideaya Biosciences 04/20/21 IDEAYA Biosciences, Inc.
Recommendations	Alliance Global raises OpGen price target to $7, sees 'eventful 2021' » 10:44 03/02/21 03/02 10:44 03/02/21 10:44 OPGN OpGen $2.12 / -0.05 (-2.30%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OPGN OpGen $2.12 / -0.05 (-2.30%) 03/01/21 OpGen wins Chinese NMPA approval for Curetis Unyvero System 02/16/21 Ares Genetics announces publication of study on prediction of AST results 01/05/21 OpGen's Curetis, Annar enter Unyvero distribution partnership 12/17/20 OpGen announces publication on Unyvero LRT BAL panel OPGN OpGen $2.12 / -0.05 (-2.30%) 11/13/20 Alliance Global Partners OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners 06/09/20 Alliance Global Partners Alliance Global Partners sees OpGen preliminary data as positive 06/03/20 Alliance Global Partners OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global OPGN OpGen $2.12 / -0.05 (-2.30%) 01/13/21 OpGen reports preliminary 2020 revenue $5.2M, consensus $4.15M 01/13/21 OpGen reports preliminary Q4 revenue $1.3M, two est. $1.4M 10/15/20 OpGen reports preliminary Q3 revenue approx. $1M, one est. $1.6M

Events

Earnings calls, analyst events, roadshows and more

DIN
Today at 12:00

Dine Brands - DIN Conference Calls
IPI
Today at 12:00

Intrepid Potash - IPI Conference Calls
NAV
Today at 12:00

Navistar International Corp. Firm Sponsored Meetings
PS
Today at 12:30

Pluralsight, Inc. Firm Sponsored Meetings
Today at 13:00

Fed Governor Speaks on US Economic Outlook Government Event

Virtual Evemt
PGR
Today at 13:00

Progressive - PGR Conference Calls
WORK
Today at 13:00

Slack Technologies, Inc. Firm Sponsored Meetings
PGR
Today at 13:00

Progressive Corporation Firm Sponsored Meetings

Virtual Meeting
SNOW
Today at 13:00

Software & Internet Industry Meetings
Today at 13:00

Consumer Goods Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Netflix price target raised to $500 from $400 at Deutsche Bank

TODAY'S FREE FLY STORIES

Get Full Fly Access